Background: COVID-19 is a pandemic disease that has no definite treatment or preventive medication until late 2020 when vaccines were developed. Vaccines are a very useful new tool against COVID-19 that stimulate the immune system after recognition of viruses or their parts. Complications post vaccination could happen and they depend on the types, vaccine mechanism of action as well as some other patients' factors. Case report: We are reporting a 39 years old lady who is known as allergic to a strawberry and kiwi, otherwise medically free. She presented to the outpatient unit with a ten-days history of palms of the hands and soles of the feet itchiness that is associated with occasional redness after receiving the first dose of COVID-19 vac...
Background: The newly developed mRNA-based COVID-19 vaccines can provoke anaphylaxis. Management of ...
To protect against COVID-19, SARS-CoV-2 vaccines have been widely used. Besides anaphylaxis, some le...
Background: Cases of immune complex vasculitis have been reported following COVID-19 infections; so ...
Vaccines are actually the most effective strategy to control the COVID-19 spread and reduce mortalit...
Introduction: Since the first reported case of Coronavirus 19 (COVID 19) outbreak, several vaccines ...
Introduction: Coronavirus disease 2019 (COVID-19) vaccines can cause adverse reactions, mainly from ...
An in-depth characterization of the incidence, morphology, and onset of COVID-19-vaccines cutaneous ...
Background: The COVID-19 mRNA vaccine was granted emergency use authorization (EUA) on December 18, ...
[[abstract]]BACKGROUND: The COVID-19 mRNA vaccine was granted emergency use authorization (EUA) on D...
Although they are poorly investigated, cutaneous reactions to messenger RNA (mRNA)-based COVID-19 va...
(1) Background: Coronavirus disease 2019 (COVID-19) vaccines are currently employed on a population-...
BACKGROUND: The coronavirus disease 2019 (COVID-19) is associated with a wide clinical spectrum of s...
The urgent requirement for a preventative vaccination became more pressing due to the severe repercu...
Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-...
Coronavirus disease 2019 (COVID-19) exhibit mild to moderate symptoms, whereas 15% of COVID-19 cases...
Background: The newly developed mRNA-based COVID-19 vaccines can provoke anaphylaxis. Management of ...
To protect against COVID-19, SARS-CoV-2 vaccines have been widely used. Besides anaphylaxis, some le...
Background: Cases of immune complex vasculitis have been reported following COVID-19 infections; so ...
Vaccines are actually the most effective strategy to control the COVID-19 spread and reduce mortalit...
Introduction: Since the first reported case of Coronavirus 19 (COVID 19) outbreak, several vaccines ...
Introduction: Coronavirus disease 2019 (COVID-19) vaccines can cause adverse reactions, mainly from ...
An in-depth characterization of the incidence, morphology, and onset of COVID-19-vaccines cutaneous ...
Background: The COVID-19 mRNA vaccine was granted emergency use authorization (EUA) on December 18, ...
[[abstract]]BACKGROUND: The COVID-19 mRNA vaccine was granted emergency use authorization (EUA) on D...
Although they are poorly investigated, cutaneous reactions to messenger RNA (mRNA)-based COVID-19 va...
(1) Background: Coronavirus disease 2019 (COVID-19) vaccines are currently employed on a population-...
BACKGROUND: The coronavirus disease 2019 (COVID-19) is associated with a wide clinical spectrum of s...
The urgent requirement for a preventative vaccination became more pressing due to the severe repercu...
Scholars around the world have dedicated themselves to developing an effective vaccine against SARS-...
Coronavirus disease 2019 (COVID-19) exhibit mild to moderate symptoms, whereas 15% of COVID-19 cases...
Background: The newly developed mRNA-based COVID-19 vaccines can provoke anaphylaxis. Management of ...
To protect against COVID-19, SARS-CoV-2 vaccines have been widely used. Besides anaphylaxis, some le...
Background: Cases of immune complex vasculitis have been reported following COVID-19 infections; so ...